Thanks for sharing. I'm curious as to what others thoughts are...

Thanks for sharing. I'm curious as to what others thoughts are on what they think "unrisked" valuation of $1.20 refers to? I mean if all these trials make it through (unrisked) then surely it's worth far, far more than $1.20? Do they mean that if PYC were valued on where they are at now, using usual industry % COS, etc... then the value would be $1.20? If so, what's with the 22c because that would already factor in risk? Or do they mean with just RP11?

Any thoughts on what they mean by this valuation, both risked and unrisked, as it seems pretty arbitrary to me (given the enormous potential)?

Thanks in advance.